Alexander Turchinets
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Alexander Turchinets has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Alla B. Guekht
Moscow Research and Clinical Center for Neuropsychiatry
4 shared publications - Mikhail Zinchuk
Moscow Research and Clinical Center for Neuropsychiatry
4 shared publications - Georgii Kustov
Moscow Research and Clinical Center for Neuropsychiatry
3 shared publications - Alexander A. Yakovlev
Institute of Higher Nervous Activity and Neurophysiology, Russian Academy of Sciences, Moscow, Russia
2 shared publications - Flora K. Rider
Moscow Research and Clinical Center for Neuropsychiatry, Moscow, Russian Federation
2 shared publications - Olga Tikhonova
Research and Clinical Center for Neuropsychiatry Moscow Russian Federation
2 shared publications
Latest Publications
- 23 October 2026
- Published by Taylor & Francis in Applied Neuropsychology: Adult
- p. 1-12
Validation of the Russian version of the cognitive functioning self‑assessment scale (CFSS) in patients with non‑psychotic mental disorders
Cognitive functions are a broad term encompassing mental processes involved in acquiring knowledge, manipulating information, and reasoning; it includes domains such as perception, memory, learning...
- 23 October 2026
- Published by Taylor & Francis in Applied Neuropsychology: Adult
- p. 1-12
Validation of the Russian version of the cognitive functioning self‑assessment scale (CFSS) in patients with non‑psychotic mental disorders
Cognitive functions are a broad term encompassing mental processes involved in acquiring knowledge, manipulating information, and reasoning; it includes domains such as perception, memory, learning...
Cross‐cultural adaptation and validation of the Russian versions of the Global Assessment of Disability Related to Seizures and Global Assessment of Severity of Epilepsy scales
Objective: The purpose of the study was to evaluate the usefulness and reliability of the Russian versions of the Global Assessment of Disability Related to Seizures (GADS) and Global Assessment of Severity of Epilepsy (GASE), as Patient‐Reported Outcomes Measures (PROMs), among patients with epilepsy (PWE) in the Russian population. Additionally, we aimed to identify predictors of seizure‐related disability and epilepsy severity in our patients. Methods: Data from 186 adult PWE consecutively enrolled in the outpatient clinic of the Moscow Research and Clinical Center for Neuropsychiatry were used to assess the validity of the scales. Clinical and demographic data were collected. Patients completed the GADS and GASE scales and a range of other measures (Neurological Disorders Depression Inventory for Epilepsy, Epilepsy Anxiety Survey Instrument—brief version, Quality of Life in Epilepsy Inventory‐31, EpiTrack, Epilepsy Stigma Scale) to assess the psychometric properties of the scales. Multiple linear regression models were developed to identify predictors of patient‐reported disability from seizures and epilepsy severity. Results: Both GADS and GASE demonstrated convergent validity, known‐groups validity, and construct validity. The most significant predictors of GADS score included the frequency of seizures, achieving 1‐year seizure freedom, official disability status, employment status, stigma, and anxiety. The main predictor of GASE scores was self‐reported disability due to seizures (GADS), followed by quality of life, frequency of seizures, stigma, and cognitive function. Significance: The study confirmed the validity and usefulness of the Russian versions of the GADS and GASE scales, which can be used in both clinical and research settings.
Cross‐cultural adaptation and validation of the Russian versions of the Global Assessment of Disability Related to Seizures and Global Assessment of Severity of Epilepsy scales
Objective: The purpose of the study was to evaluate the usefulness and reliability of the Russian versions of the Global Assessment of Disability Related to Seizures (GADS) and Global Assessment of Severity of Epilepsy (GASE), as Patient‐Reported Outcomes Measures (PROMs), among patients with epilepsy (PWE) in the Russian population. Additionally, we aimed to identify predictors of seizure‐related disability and epilepsy severity in our patients. Methods: Data from 186 adult PWE consecutively enrolled in the outpatient clinic of the Moscow Research and Clinical Center for Neuropsychiatry were used to assess the validity of the scales. Clinical and demographic data were collected. Patients completed the GADS and GASE scales and a range of other measures (Neurological Disorders Depression Inventory for Epilepsy, Epilepsy Anxiety Survey Instrument—brief version, Quality of Life in Epilepsy Inventory‐31, EpiTrack, Epilepsy Stigma Scale) to assess the psychometric properties of the scales. Multiple linear regression models were developed to identify predictors of patient‐reported disability from seizures and epilepsy severity. Results: Both GADS and GASE demonstrated convergent validity, known‐groups validity, and construct validity. The most significant predictors of GADS score included the frequency of seizures, achieving 1‐year seizure freedom, official disability status, employment status, stigma, and anxiety. The main predictor of GASE scores was self‐reported disability due to seizures (GADS), followed by quality of life, frequency of seizures, stigma, and cognitive function. Significance: The study confirmed the validity and usefulness of the Russian versions of the GADS and GASE scales, which can be used in both clinical and research settings.
- 28 August 2025
- Published by Elsevier in Epilepsy & Behavior
- Vol. 172, 110676
The Epilepsy Surgery Satisfaction Questionnaire (ESSQ-19): linguistic adaptation and validation of the Russian version
- 28 August 2025
- Published by Elsevier in Epilepsy & Behavior
- Vol. 172, 110676
The Epilepsy Surgery Satisfaction Questionnaire (ESSQ-19): linguistic adaptation and validation of the Russian version
- 15 November 2023
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 123 (10) , 7-16
Modern ideas about the relationship between fibromyalgia and mental disorders
Fibromyalgia (FM) is a pain syndrome with a high burden and an understudied etiology and pathogenesis. There is now considerable evidence that FM has a strong bidirectional relationship with psychiatric disorders and is associated with certain personality traits that contribute to the severity of key somatic symptoms and affect overall prognosis. In this article, the authors present data from recent epidemiological and neurobiological studies, discuss the multilevel relationship between FM and psychiatric disorders, and briefly review approaches to the treatment of co-morbid conditions.
- 15 November 2023
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 123 (10) , 7-16
Modern ideas about the relationship between fibromyalgia and mental disorders
Fibromyalgia (FM) is a pain syndrome with a high burden and an understudied etiology and pathogenesis. There is now considerable evidence that FM has a strong bidirectional relationship with psychiatric disorders and is associated with certain personality traits that contribute to the severity of key somatic symptoms and affect overall prognosis. In this article, the authors present data from recent epidemiological and neurobiological studies, discuss the multilevel relationship between FM and psychiatric disorders, and briefly review approaches to the treatment of co-morbid conditions.